X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.410
+0.450 (11.36%)
At close: Jul 10, 2026, 4:00 PM EDT
4.370
-0.040 (-0.91%)
After-hours: Jul 10, 2026, 6:16 PM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or -68.53% compared to the previous year.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$200,311
Profits / Employee
-$2,216,044
Market Cap
415.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -98 | -68.53% |
| Dec 31, 2024 | 143 | 50 | 53.76% |
| Dec 31, 2023 | 93 | 23 | 32.86% |
| Dec 31, 2022 | 70 | -13 | -15.66% |
| Dec 31, 2021 | 83 | 11 | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Puma Biotechnology | 179 |
| Fate Therapeutics | 161 |
| Lyell Immunopharma | 161 |
| Foghorn Therapeutics | 106 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
| Immuneering | 55 |
XFOR News
- 12 hours ago - X4 Pharmaceuticals initiated with an Overweight at Wells Fargo - TheFly
- 3 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 9 days ago - X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board - TheFly
- 9 days ago - X4 Pharmaceuticals Appoints Kelly Gold, Experienced Chief Financial Officer, to its Board of Directors - GlobeNewsWire
- 5 weeks ago - X4 Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - X4 Pharmaceuticals initiated with an Outperform at Leerink - TheFly
- 5 weeks ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire